| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5874064 | Journal of Stroke and Cerebrovascular Diseases | 2014 | 7 Pages |
Abstract
To our knowledge, this is the first, phase II, pilot clinical trial to investigate the safety and efficacy of intravenous administration of allogeneic MSCs from adipose tissue within the first 2Â weeks of stroke. In addition, its results will help us define the best criteria for a future phase III study.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Exuperio MD, PhD, FAHA, FESO, MarÃa BS, PhD, Patricia MD, PhD, Berta BS, PhD, Gerardo MD, PhD, Manuel Lara MD, Blanca Fuentes MD, PhD,